Studying the genetics of Alzheimer’s disease
The launch of the U.S POINTER study at AAIC 2017
Amyloid aggregation in cognitively healthy, elderly identical twins
Pieter Jelle Visser
What do biomarkers mean for the treatment of Alzheimer’s disease?
Progress in developing novel drugs for the treatment of dementia